NYSEAMERICAN:KNW Know Labs (KNW) Stock Price, News & Analysis $2.14 +0.08 (+3.83%) Closing price 08/14/2025Extended Trading$2.14 0.00 (0.00%) As of 08/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock Analysis About Know Labs Stock (NYSEAMERICAN:KNW) Get Know Labs alerts:Sign Up Key Stats Today's Range$2.00▼$2.1750-Day Range$2.14▼$2.1452-Week Range$0.39▼$5.36Volume612,050 shsAverage Volume4.38 million shsMarket Capitalization$16.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Know Labs, Inc. (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness. The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways. Know Labs has assembled a patent portfolio covering hardware design, signal analysis and data‐interpretation methods, and is collaborating with academic and industry partners to refine its technology. These collaborations are intended to demonstrate the accuracy, reliability and safety of non‐invasive measurements across applications in diabetes management, sports performance, consumer wellness and beyond. Headquartered in the United States, Know Labs is positioning its Bio‐RFID platform for global deployment, with initial emphasis on markets that demand painless, continuous biomarker tracking. The management team brings together expertise in biomedical engineering, product development and medical‐device commercialization. As the company advances toward regulatory clearance and potential strategic partnerships, it aims to license its technology to device manufacturers or offer integrated solutions directly to end users.AI Generated. May Contain Errors. Read More Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KNW Stock News HeadlinesKnow Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% - Should You Buy?September 2, 2026 | americanbankingnews.comUSBC: Greg Kidd's Bitcoin Treasury And Stablecoin PivotSeptember 23, 2025 | seekingalpha.comUnder $1… and Wall Street already knows about itYou've seen the crypto market… it's absolutely on fire. And the biggest catalyst could be up next. September 15. That's when the Senate's cloture motion on the Clarity Act is scheduled to come due… the first major floor test for a bill designed to finally give America clear rules for digital assets. The market is rallying before that vote even happens... Crypto is already ripping before the most important bill for the market has passed. We believe we've found the altcoin that could benefit the most from this bill… And given the current move in the market, we are recommending it right now.September 8 at 1:00 AM | Crypto 101 Media (Ad)Know Labs Approves Key Amendments at Stockholder MeetingAugust 1, 2025 | tipranks.comKnow Labs, Inc. Announces Adjournment of Special Meeting of StockholdersJuly 24, 2025 | businesswire.comKnow Labs Reminds its Stockholders to Vote Ahead of the Special Meeting on July 24July 22, 2025 | businesswire.comNYSE:KNW Financials | Know Labs Inc - Investing.comJuly 2, 2025 | investing.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of ShareholdersJune 12, 2025 | prnewswire.comSee More Headlines KNW Stock Analysis - Frequently Asked Questions How have KNW shares performed this year? Know Labs' stock was trading at $2.1390 at the beginning of 2026. Since then, KNW stock has increased by 0.0% and is now trading at $2.1390. How were Know Labs' earnings last quarter? Know Labs, Inc. (NYSEAMERICAN:KNW) released its earnings results on Friday, February, 14th. The company reported ($1.60) earnings per share for the quarter. Read the conference call transcript. When did Know Labs' stock split? Know Labs's stock reverse split on the morning of Tuesday, February 18th 2025.The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Know Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Broadcom (AVGO), Arista Networks (ANET), NVIDIA (NVDA), Adobe (ADBE), Disc Medicine (IRON), Jabil (JBL) and AppLovin (APP). Company Calendar Last Earnings2/14/2025Today9/08/2026Fiscal Year End9/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorTechnology Industry IT Services Sub-IndustryN/A Current SymbolNYSEAMERICAN:KNW Previous SymbolOTCMKTS:KNWN CIK1074828 Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.58 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-809.17% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual Sales$4.36 million Price / Sales3.68 Cash FlowN/A Price / Cash FlowN/A Book Value($0.80) per share Price / Book-2.67Miscellaneous Outstanding Shares7,500,000Free Float4,815,000Market Cap$16.04 million OptionableNot Optionable Beta1.83 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSEAMERICAN:KNW) was last updated on 9/8/2026 by MarketBeat.com Staff. From Our PartnersEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredForget SpaceX, Elon Is Now Powering the Next Hot IPOElon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 time...Brownstone Research | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Know Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.